Found: 28
Select item for more details and to access through your institution.
Outcomes of older adults with early-stage triple-negative breast cancer (TNBC) receiving chemotherapy: a single-institution experience.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 207, n. 1, p. 81, doi. 10.1007/s10549-024-07309-7
- By:
- Publication type:
- Article
Outcomes of male patients with HR+/HER2– advanced breast cancer receiving palbociclib in the real-world POLARIS study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 463, doi. 10.1007/s10549-023-07145-1
- By:
- Publication type:
- Article
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 3, p. 457, doi. 10.1007/s10549-023-06929-9
- By:
- Publication type:
- Article
Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer.
- Published in:
- Neurotoxicity Research, 2020, v. 37, n. 4, p. 788, doi. 10.1007/s12640-019-00158-z
- By:
- Publication type:
- Article
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 509, doi. 10.1007/s10637-020-00995-2
- By:
- Publication type:
- Article
Predicting Long-Term Cognitive Outcome Following Breast Cancer with Pre-Treatment Resting State fMRI and Random Forest Machine Learning.
- Published in:
- Frontiers in Human Neuroscience, 2017, p. 1, doi. 10.3389/fnhum.2017.00555
- By:
- Publication type:
- Article
Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16<sup>INK4a</sup>.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 6, p. 1, doi. 10.1093/jncics/pkaa082
- By:
- Publication type:
- Article
Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 160, n. 1, p. 101, doi. 10.1007/s10549-016-3986-6
- By:
- Publication type:
- Article
Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.
- Published in:
- Transplant International, 2013, v. 26, n. 6, p. 616, doi. 10.1111/tri.12091
- By:
- Publication type:
- Article
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 6, p. 1474, doi. 10.1002/cam4.4566
- By:
- Publication type:
- Article
Delayed initiation of adjuvant chemotherapy in older women with breast cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 19, p. 6961, doi. 10.1002/cam4.3363
- By:
- Publication type:
- Article
Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 589, doi. 10.1007/s40801-023-00391-1
- By:
- Publication type:
- Article
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers.
- Published in:
- Nature Communications, 2017, v. 8, n. 6, p. 15916, doi. 10.1038/ncomms15916
- By:
- Publication type:
- Article
Severe hyponatremia following cyclophosphamide infusion in breast cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Evaluating Adverse Events in Patients with Breast Cancer and HIV Infection Receiving Concomitant Antiretroviral Therapy and Chemotherapy with Curative Intent.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 2, p. 66
- By:
- Publication type:
- Article
Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 17, p. 2945, doi. 10.1002/cncr.32175
- By:
- Publication type:
- Article
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Potentially inappropriate medication use in older patients with breast and colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Frequency of mesenchymal-epithelial transition factor gene ( MET) and the catalytic subunit of phosphoinositide-3-kinase ( PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 1, p. 7, doi. 10.1002/cncr.27608
- By:
- Publication type:
- Article
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00473-3
- By:
- Publication type:
- Article
Patient‐Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 762, doi. 10.1634/theoncologist.2018-0590
- By:
- Publication type:
- Article
Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-A National Cancer Database analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 957, doi. 10.1002/cncr.33329
- By:
- Publication type:
- Article
Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 5, p. 2515, doi. 10.1007/s12325-023-02471-8
- By:
- Publication type:
- Article
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
- Published in:
- JMIR Cancer, 2022, v. 8, n. 2, p. 1, doi. 10.2196/33859
- By:
- Publication type:
- Article